Search

Your search keyword '"Wang, Mei-Lun"' showing total 189 results

Search Constraints

Start Over You searched for: Author "Wang, Mei-Lun" Remove constraint Author: "Wang, Mei-Lun"
189 results on '"Wang, Mei-Lun"'

Search Results

2. Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study

3. Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell–Fibroblast Crosstalk

5. Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)

7. A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients With Moderately to Severely Active Crohn’s Disease

10. Eosinophilic esophagitis

14. BMP-driven NRF2 activation in esophageal basal cell differentiation and eosinophilic esophagitis

16. Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study

17. Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell–Fibroblast Crosstalk

19. Thymic stromal lymphopoietin--elicited basophil responses promote eosinophilic esophagitis

20. TLR3-mediated NF-[kappa]B signaling in human esophageal epithelial cells

22. Immune-mediated signaling in intestinal goblet cells via PI3-kinase-and AKT-dependent pathways

23. Regulation of RELM/FIZZ isoform expression by Cdx2 in response to innate and adaptive immune stimulation in the intestine

24. TSLP-elicited basophil responses mediate the pathogenesis of eosinophilic esophagitis: 282

27. Contributors

28. Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

31. Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)

32. Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension

33. FRI0181 THE PLUTO STUDY: INTRAVENOUS BELIMUMAB IN CHILDREN WITH SYSTEMIC LUPUS ERYTHEMATOSUS

34. Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension.

35. Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers

36. Eosinophilic Esophagitis-Associated Chemical and Mechanical Microenvironment Shapes Esophageal Fibroblast Behavior

38. Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE)

39. Autophagy mediates epithelial cytoprotection in eosinophilic oesophagitis

44. 526 Autophagy Is an Epithelial Cytoprotective Mechanism in Esophageal Epithelial Cells in Response to Eosinophilic Esophagitis-Associated Inflammation

46. Su1114 Autophagy-Related Gene 7 (ATG7) May Serve As a Biomarker of EoE Disease Status

47. Altered Esophageal Histamine Receptor Expression in Eosinophilic Esophagitis (EoE): Implications on Disease Pathogenesis

49. GWAS identifies four novel eosinophilic esophagitis loci

Catalog

Books, media, physical & digital resources